Quick Answer
There is no dedicated randomized controlled trial testing hyperbaric oxygen therapy specifically as an insomnia treatment. What exists instead is secondary evidence: sleep quality improvements have been reported as a secondary outcome in HBOT trials for other conditions — including fibromyalgia and post-concussion syndrome — where patients receiving HBOT at clinical pressure reported better sleep alongside improvement in their primary condition. This is suggestive, not proof that HBOT treats insomnia directly.
Why Sleep Shows Up as a “Side Finding” in HBOT Research
Sleep is deeply connected to pain, inflammation, stress, and neurological function — which means it tends to improve or worsen alongside whatever primary condition a clinical trial is actually studying. Researchers running HBOT trials for other conditions often include sleep quality questionnaires (like the Pittsburgh Sleep Quality Index) as one of several outcome measures, and results tend to move in the same direction as the primary outcome.
This is useful information, but it’s important to be precise about what it does and doesn’t tell us: it suggests sleep quality can improve when HBOT successfully treats an underlying condition contributing to poor sleep — not that HBOT is a standalone insomnia treatment independent of any other condition.
What the Secondary Evidence Shows
| Study | Primary Focus | Sleep Finding |
|---|---|---|
| Harch et al. (2017), post-concussion/PTSD | Cognitive and PTSD symptoms | Improved sleep reported alongside symptom reduction, at 1.5 ATA |
| Boussi-Gross et al. (2013), chronic mild TBI | Cognitive function | Quality-of-life measures including sleep showed improvement |
Notice the pattern: in every case, sleep improvement was measured as one part of a broader recovery from a specific diagnosed condition — chronic pain, post-concussion symptoms — not as the primary target of the intervention. Nobody has run a trial where the entry criteria was simply “adults with insomnia” and HBOT was tested as the treatment.
Why This Distinction Matters
If your sleep problems are secondary to something HBOT has actual trial evidence for — chronic pain conditions like fibromyalgia, for instance — then addressing the underlying condition through appropriate clinical treatment might reasonably improve sleep as a byproduct. That’s a legitimate, if indirect, connection.
If your sleep problems are primary insomnia without an underlying condition HBOT has been studied for, there’s currently no direct evidence to support HBOT as the intervention — standard evidence-based insomnia treatments (CBT-I, sleep hygiene protocols, and where appropriate, medication) have a far larger and more specific research base for this exact problem.
Where Mild HBOT Realistically Fits Into a Sleep Routine
This is actually one of the more honest use cases for mild hyperbaric chambers, and we can say it plainly: many users of mild HBOT report using sessions in the evening as part of a wind-down routine — a quiet, low-stimulation period without screens, in a controlled environment. We’re not claiming this is a clinically proven insomnia treatment. We’re describing how people actually use general wellness equipment, the same way they might use a weighted blanket, white noise machine, or a consistent pre-bed routine.
The AURA One is built with this kind of use in mind — quiet operation under 50 dB (important for anyone sensitive to noise while trying to relax), dimmable interior lighting, and a session timer that allows for a consistent, repeatable wind-down routine. This is a wellness and relaxation framing, not a medical insomnia treatment claim.
FAQ
No dedicated insomnia trial exists. Sleep improvements have been documented as secondary findings in trials for other conditions, like fibromyalgia and post-concussion syndrome, at clinical pressures of 1.5–2.0 ATA.
Based on the available evidence, sleep improvement appears connected to improvement in the primary condition being treated (pain, cognitive symptoms), rather than a standalone effect on sleep itself.
Cognitive behavioral therapy for insomnia (CBT-I) has the strongest evidence base for chronic insomnia and is generally recommended as a first-line approach by sleep medicine specialists.
Many users incorporate mild HBOT sessions into an evening wind-down routine for general relaxation. This isn’t the same as clinical proof it treats insomnia, but a quiet, screen-free relaxation period is a reasonable component of general sleep hygiene.
This article is for educational purposes only and is not medical advice. There is no dedicated clinical trial establishing HBOT as an insomnia treatment; available evidence is secondary to trials for other conditions. Anyone with chronic insomnia should consult a physician or sleep medicine specialist. HyperbaricO2Care manufactures mild hyperbaric chambers (1.1–1.7 atm) intended for general wellness use and does not claim its equipment treats insomnia or sleep disorders. References: Efrati et al., PLOS ONE (2015); Harch et al., Journal of Neurotrauma (2017); Boussi-Gross et al., PLOS ONE (2013).